PARP1 and cardiovascular disorder: In cardiovascular diseases, PARPi, such as 3-AB, PJ-34, INO-1001, BGP-15, and GPI 6150, reduce the consumption of NAD+ and ATP by inhibiting the overactivation of PARP1, thereby alleviating oxidative stress and inflammatory responses and protecting cells from necrosis.